Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Rooswinkel

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|April 15, 2014
Acquiring orphansRogier Rooswinkel, Geert-Jan Mulder, Sander van Deventer
Radiation Oncology (London, England)|October 27, 2009
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosisShuraila F Zerp, Rianne Stoter, Gitta Kuipers, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|April 15, 2014
Acquiring orphansRogier Rooswinkel, Geert-Jan Mulder, Sander van Deventer
Radiation Oncology (London, England)|October 27, 2009
AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosisShuraila F Zerp, Rianne Stoter, Gitta Kuipers, et al.
Pageof 1